Kevin Kim

Kevin Kim has extensive work experience in the biotechnology and pharmaceutical industries. In 2023, they joined miRecule, Inc. as VP of Discovery. Prior to that, they were Vice President at an RNA startup from October 2022. From 2019 to 2022, they worked at Sarepta Therapeutics, first as Senior Director of Discovery Biology and then as Director of Lead Discovery. Kevin also had roles at Wave Life Sciences as a Scientist leading a CNS project, Auransa Inc. as Associate Director of Research, and Stem Cell Theranostics as Principal Scientist and R&D Director. Kevin started their career as a Postdoctoral Scientist and Project Scientist at Cedars-Sinai and Harvard University, respectively. Kevin also worked as a Scientist and Team Leader of Stem Cell Research at GlaxoSmithKline from 2008 to 2010.

Kevin Kim has a Ph.D in Molecular and Medical Pharmacology from UCLA. Kevin also has a Bachelor of Science degree in Neuroscience, also obtained from UCLA.